Session 5: New pathways with potential impact in the treatment of early breast cancer

Chairs: Masazaku Toi (Japan), Jiang Zefei (China)

• Targeting DNA repair (Andrew Tutt, UK)
• Targeting the CDK 4‐6 pathway (Nicholas Turner, UK)
• Targeting immune pathway (Sherene Loi, Australia)
• How the recent data from metastatic trials inform us on treatment opportunities for patients with early breast cancer? (Fatima Cardoso, Portugal)

BCC2019 PARTICIPANT: PASSWORD in BCC e-mail from March 23.